Elasomeran - CISMeF

Preferred Label : Elasomeran;

NCIt synonyms : LNP-encapsulated mRNA-based SARS-CoV-2 Vaccine mRNA-1273; Moderna COVID-19 Vaccine; Lipid Nanoparticle-encapsulated mRNA-based SARS-CoV-2 Vaccine mRNA-1273;

NCIt related terms : mRNA-1273 (Moderna);

NCIt definition : A vaccine consisting of a lipid nanoparticle (LNP) encapsulating a messenger RNA (mRNA) encoding the full-length, prefusion stabilized spike (S) protein of SARS-CoV-2, with potential immunizing activity against SARS-CoV-2. Upon administration of elasomeran, the lipid nanoparticle binds to the plasma membrane of cells and releases the mRNA into the cells. The mRNA is then translated by ribosomes to produce the SARS-CoV-2 S protein. This may activate both humoral and cellular immune responses which may result in protection against SARS-CoV-2 infection.;

UNII : EPK39PL4R4;

CAS number : 2417899-77-3; 2430046-03-8; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2417899-77-3 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2430046-03-8 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Spikevax;

Molecule name : mRNA 1273; mRNA-1273; CX-024414; M-1273; TAK-919;

NCI Metathesaurus CUI : CL1787495;

Details

Origin ID

C172736;

UMLS CUI

C5422751;

Automatic exact mappings (from CISMeF team)
- Moderna covid-19 vaccine [MeSH concept]
Currated CISMeF NLP mapping
- 2019-nCoV Vaccine mRNA-1273 [MeSH Descriptor]
- Elasomeran [MeSH concept]
Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- 2019-nCoV Vaccine mRNA-1273 [MeSH Descriptor]
- Elasomeran (substance) [SNOMED CT concept]
concept_is_in_subset
- ACC/AHA COVID-19 Appendix Authorized Values [NCIt concept]
- ACC/AHA Cardiovascular and Noncardiovascular Complications of COVID-19 Terminology [NCIt concept]
- Appendix 8: Pharmacological Therapy Terminology [NCIt concept]
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]
- SeroNet Authorized Values [NCIt concept]
- SeroNet Study Descriptors [NCIt concept]
- Therapies for COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients